Dr. Sanjeev Kumar
Dr. Kumar removes a large tumor at surgery during a life saving operation.
Dr. Sanjeev Kumar-A Leading Pelvic Surgeon
Dr. Sanjeev Kumar, MD was the 8th most prolific robotic surgeon in the U.S.A. by volume, according to the Baptist Cancer Center annual report of 2017. As noted in the excerpts from the Baptist cancer center annual report in 2017-Dr. Kumar joined the Baptist Cancer Center in Memphis TN in 2013 as a division director of gynecologic oncology. Dr. Kumar’s work at Baptist involved many fronts, particularly helping morbidly obese women suffering from lack of care options. In 2017, Dr. Kumar became the 8th busiest surgeon in the US using the robotic surgery approach in gynecologic cancers. According the Dr. Kumar, Robotics is the future of surgery as it gives very reliable results and reduces the human hand variation in the art of surgery.
By the 3rd quarter of 2017, Dr. Kumar had performed 285 robotic procedures with 95 percent of patients considered morbidly obese. Often rejected as candidates for surgery due to weights exceeding 400 pounds, these patients have few options due to greater risk of wound infection, blood loss and pulmonary complications.
Through his dedication to training on the robotic technologies, developing and training his OR teams, and educating patients about the risks, he created hope for this particular population of women. Dr. Kumar said-“Our program is functioning really well. We have established a culture and training by building a system and the team.
Dr. Kumar also started a novel program of HIPEC (Hyperthermic Intraperitoneal Chemotherapy) for treatment of advanced and recurrent ovarian and primary peritoneal cancers while at the Baptist Cancer Center. He also participated with the NCORP grant through research studies. It is noteworthy that the HIPEC program started by Dr. Kumar in Baptist in 2017 was one of the newest services at the Baptist hospital.
Dr. Sanjeev Kumar was the first surgeon to perform a robotic cervical cerclage in the city of Memphis on a outpatient basis leading to discharge of the patient on the same day. This operation was called as a breakthrough by the local media as it helped local people in the memphis to achieve the dreams of having a family. Before he performed this operation in the memphis community, the patients and their family had to travel far away in other cities to get this operation done. They will go to Chicago in the North and Dallas in the south. Once Dr. Kumar started performing these surgeries in the City of memphis, the crucial and novel treatment could be provided in the the city itself, helping the local community.
https://www.actionnews5.com/2019/02/07/breakthrough-medical-procedure-can-help-prevent-miscarriage/
Thank you letter from the CEO of the Baptist Hospital in Tipton, TN for Dr. Kumar for the selfless act of saving a life of a bleeding patient.
Dr. Kumar trains the residents from the University of Tennessee, Obstetrics and Gynecology program in Robotic Surgery skills.
Dr. Sanjeev Kumar-Surgical Teacher
Dr. Kumar enjoyed teaching students and residents. Residents routinely rotated with Dr. Kumar and learned skills needed to conduct advanced pelvic surgery from him. He trained residents from University of Tennessee in Memphis campus from the Department of Obstetrics and Gynecology. Kumar also taught the residents how to perform robotic hysterectomy & complex pelvic surgery utilizing robotic and laparoscopic equipment. Dr. Kumar routinely helped other physicians in complex surgical cases as and when needed; often in the middle of the night on a voluntary basis.
Dr. Kumar worked with the Medicos group which is famous for looking after underprivileged populations.The medicos group provides care to indigenous population during pregnancy and afterwards. Dr. Kumar was the surgical expert that was on backup call for the medicos group for several years in Memphis Tennessee. During this time whenever there was a surgical emergency and the Medicos group physicians needed help; they will call Dr. Kumar and he will scrub in to help out, often saving several patient lives during this process. Dr. Kumar also provided valuable teaching to the physicians of the Medicos group as well as the fellowship program run by the same group.The Medicos group provides valuable services to otherwise unreserved population of patients. A large fraction of these patients speak spanish and the prevalence of pelvic pathology is very high in this group of patients.
Dr. Kumar also trained residents from the Department of Obstetrics and Gynecology from Meharri UniversityIn Nashville Tennessee. This group of residents will rotate in Memphis with Memphis physicians and surgeons and during these rotations these residence routinely worked with Dr. Kumar at the Methodist Germantown Hospital learning valuable skills in pelvic surgery from him. These skills included cases such as robotic hysterectomy, ectopic pregnancy resections and cancer surgeries in the female pelvis.
Dr. Sanjeev Kumar’s contributions to the MidSouth community
Dr. Kumar extended cutting edge modern care to the MidSouth community through a chain of clinics with the Baptist Healthcare Corporation. He established the cancer clinics in 3 states and serviced the underserved population of the region.
Excerpt from the Baptist cancer center annual report in 2016
Dr. Kumar, while working with the Baptist Medical group, extended new and cutting edge technologies to the Midsouth region. In the annual report of the 2016 from the baptist cancer center, the organization noted-that Dr. Kumar devoted about 70 percent of his time in operating on patients with gynecologic cancers, primarily focusing on the minimally invasive techniques. Dr. Kumar, also focused his efforts on a newer form of chemotherapy for cancer, the HIPEC. In the HIPEC approach, the surgeon bathes the abdominal cavity of a patient with warm chemotherapy solution immediately after the surgical resection of a cancer. This program was spearheaded by Dr. Kumar at the Baptist cancer center and he provided these services to the patients in the Midsouth region via the Baptist healthcare network. A central philosophy of Dr. Kumar is to bring the care closer to home, where the patient lives, hence he provided care in Jonesboro AR, Memphis TN, Oxford MS and Southaven MS as well; through the chain of satellite clinics.
A thank you note from the CEO of the Baptist Hospital in Tipton, TN. Dr. Kumar drove to Tipton many a times to help in surgical emergencies to save patient lives on a voluntary basis.
Cheritable Works
Heart to heart foundation supports free heart surgery in children. Sunil Gavaskar, a legendary cricket player from India works to fundraise for the heart to heart foundation. Dr. Sanjeev Kumar worked with the heart to heart foundation with generous donations to help fund the cause for the life saving surgeries for children in need, along with Mr. Sunil Gavaskar in Memphis, TN.
https://www.h2h.foundation/
Charitable Care
Dr. Sanjeev Kumar believed every patient in our community needs the beast healthcare, irrespective to the type of insurance they have. Following this principle, he provided tremendous healthcare to patients even if they did not have healthcare insurance. In his practice, he never turned away any patients based on their paying capability. Frequently, Dr. Kumar performed lifesaving surgery on patients who did not have insurance or paying capability. Attached is example of one such patient, where Dr. Kumar performed cancer surgery on uninsured patient free of cost. This grateful patient, C.J. writes-“to each and everyone that has touched my life, words can not express how much I appreciate how thankful I am, how grateful I am, charity care you have shine on me giving me glory and brilliance in the lord. I am a witness of all the amazing things you do, I thank the lord and charity care for allowing me to see another day. God Bless.”
Charitable Donations
Dr. Kumar generously donated funds for the scholarship program for the Ms Tennessee Volunteer scholarship program. His contributions helped fund study of deserving students.
Donations to the Prison Professors Charitable Corporation.
Dr. Kumar makes monthly donation to the Prison Professors Charitable Corporation. Through these donations, he helps deliver educational programs in prisons and jails that build accountability, goal setting and practical skills for reentry. It also helps facilitate reentry support by serving as a bridge to community connections after the release. These donations also help provide scholarships and paid assignments that give returning citizens the opportunity to rebuild stability and independence. https://www.prisonprofessors.org/
Testimonials
Students
Patients
Staff
Dr. Sanjeev Kumar, MD Research
Awards
In 2006-2007, Dr. Sanjeev Kumar MD was elected for Excellence in Academic Achievement by Wayne State University School of Medicine and Hutzel Women's Hospital during his residency in Obstetrics & Gynecology.
2008-The MICHIGAN SECTION of the THE AMERICAN COLLEGE OF OBSTETRICIANS & GYNECOLOGISTS Presented FIRST PLACE RESIDENT RESEARCH - ORAL PRESENTATION award to Dr. Sanjeev Kumar MD for presenting his research on the -“Molecular Profiling of the Recurrent Endometroid Carcinoma of the Uterine Corpus”. On May 28, 2008, at James B. Henry Center, Lansing, Michigan.
2008-Southeast Michigan Center for Medical Education awarded the Third Place certificate on Sanjeev Kumar, MD in recognition of Excellence in Research for the research study which was presented by Dr. Kumar at the SEMCME Research Forum on the twenty-first day of May, 2008
2008-Southeast Michigan Center for Medical Education awarded the Excellence in Clinical Research certificate on Sanjeev Kumar, MD in recognition of Excellence in Research for the research study which was presented by Dr. Kumar at the SEMCME Research Forum on the twenty-first day of May, 2008
In 2008, Dr. Sanjeev Kumar was awarded first place honors at the Wayne State University, Detroit medical center, Sinai Grace Hospital Research day on April 17, 2008 for his clinical research oral presentation.
2009-2010 Wayne State University School of Medicine and Detroit Medical Center Sanjeev Kumar, M.D. was selected for the DMC Guild Research Award For Excellence During Residency Training, Ist Place.
2009-2010 Wayne State University School of Medicine and Detroit Medical Center Sanjeev Kumar, M.D. was selected for the Malone Award For Excellence in Gynecologic Oncology
2009-2010 Wayne State University School of Medicine and Detroit Medical Center Sanjeev Kumar, M.D. was selected for Excellence in Academic Achievement 2009 - 2010.
2017. In 2017, the Christian Brothers University (CBU) physician assistant studies program awarded the outstanding clinical preceptor award to Dr. Sanjeev Kumar, MD for his noteworthy contributions to the education of the CBU PA students on May 12, 2017.
2024. In 2024, Dr. Kumar was awarded The SURGEON of EXCELLENCE in ROBOTIC SURGERY. He was ACCREDITED WITH the Saint Francis Hospital Memphis. https://www.surgicalreview.org/
B. Selected Peer-Reviewed Publications-Chronological Order.
1. Imudia AN, Kumar S, Saed GM, Diamond MP. Pathogenesis of Intra-abdominal and pelvic adhesion development. Semin Reprod Med. 2008 Jul;26(4):289-97. PMID: 18756406
2. Kumar S, Shah JP, Bryant CS, Imudia AN, Cote ML, Ali-Fehmi R, Malone JM Jr, Morris RT. The prevalence and prognostic impact of lymph node metastasis in malignant germ cell tumors of the ovary. Gynecol Oncol. 2008 Aug;110(2):125-32. PMID: 18571705 (Lead article, Gynecol Oncol. August 2008).
3. Shah JP, Kumar S, Bryant CS, Ali-Fehmi R, Malone JM Jr, Deppe G, Morris RT. A population-based analysis of 788 cases of yolk sac tumors: A comparison of males and females. Int J Cancer. 2008 Sep 2; 123(11):2671-2675. PMID: 18767035
4. Shah JP, Bryant CS, Kumar S, Ali-Fehmi R, Malone JM Jr, Morris RT. Lymphadenectomy and ovarian preservation in low-grade endometrial stromal sarcoma. Obstet Gynecol. 2008 Nov;112(5):1102-8. PMID: 18978112.
5. Kumar S, Shah JP, Bryant CS, Imudia AN, Ali-Fehmi R, Malone JM Jr, Morris RT. Prognostic significance of keratinization in squamous cell cancer of uterine cervix: a population based study. Arch Gynecol Obstet. 2008 Nov 29. PMID: 19043726.
6. Kumar S, Shah JP, Bryant CS, Seward S, Ali-Fehmi R, Morris RT, Malone JM Jr. Radiation-Associated endometrial cancer. Obstet Gynecol. 2009 Feb;113(2, Part 1):319-325. PMID: 19155901
7. Kumar S, Bryant CS, Chamala S, Qazi A, Steffes CP, Weaver DW, Morris R, Malone JM, Shammas MA, Seward S, Pal J, Prasad M, Batchu RB. Ritonavir blocks AKT signaling, activates apoptosis and inhibits migration and invasion in ovarian cancer cells. Mol Cancer. 2009 Apr 22;8(1):26. PMID: 19386116
8. Kumar S, Jay P Shah, Christopher S Bryant, Awoniyi O Awonuga, Anthony N Imudia, Julie J Ruterbusch, Michele L Cote, Rouba Ali-Fehmi, Robert T Morris, John M Malone Jr. Second Neoplasms in survivors of endometrial cancer: Impact of radiation therapy. Gynecologic Oncology, Volume 113, Issue 2, May 2009, Pages 233- 239, PMID:19249081
9. Kumar S, Shah JP, Bryant CS, Imudia AN, Morris RT, Malone JM Jr. A comparison of younger versus older women with vulvar cancer in the United States. Am J Obstet Gynecol. 2009 May;200(5):e52-5. PMID: 19110228
10. Haitham Arabi, Hui Guan, Kumar S, Michele Cote, Sudeshna Bandyopadhyay, Christopher Bryant, Jay Shah, Fadi W. Abdul-Karim, Adnan R. Munkarah, Rouba Ali-Fehmi. Impact of microsatellite instability (MSI) on survival in high grade endometrial carcinoma. Gynecologic Oncology, Volume 113, Issue 2, May 2009, Pages 153-158, PMID: 19275958.
11. Kumar S, Shah JP, Malone JM Jr. Vulvar cancer in women less than fifty in United States, 1980-2005. Gynecol Oncol. 2009 Jan;112(1):283-4; PMID: 18692883
12. Kumar S, Morris RT, Malone JM Jr. Relative mortality in the women over 60 years of age with cervical cancer. Gynecol Oncol. 2009 Feb;112(2):437 PMID: 18544458
13. Bryant CS, Kumar S, Chamala S, Shah J, Pal J, Haider M, Seward S, Qazi AM, Morris R, Semaan A, Shammas MA, Steffes C, Potti RB, Prasad M, Weaver DW, Batchu RB. Sulforaphane induces cell cycle arrest by protecting RB-E2F-1 complex in epithelial ovarian cancer cells. Mol Cancer. 2010 Mar 2;9(1):47.
14. Kumar S, Munkarah A, Arabi H, Bandyopadhyay S, Semaan A, Hayek K, Garg G, Morris R, Ali-Fehmi R. Prognostic analysis of ovarian cancer associated with endometriosis. Am J Obstet Gynecol. 2010 Nov 10. PMID: 21074136
15. Kumar S, Mahdi H, Bryant C, Shah JP, Garg G, Munkarah A. Clinical trials and progress with paclitaxel in ovarian cancer. Int J Womens Health. 2010 Nov 19;2:411-27.PMID: 21270965
16. Garg G, Shah JP, Liu JR, Bryant CS, Kumar S, Munkarah A, Morris RT. Validation of tumor size as staging variable in the revised international Federation of gynecology and obstetrics stage I leiomyosarcoma: a population-based study. Int J Gynecol Cancer. 2010 Oct;20(7):1201-6.PMID: 20940535
17. Garg G, Shah JP, Kumar S, Bryant CS, Munkarah A, Morris RT. Ovarian and uterine carcinosarcomas: a comparative analysis of prognostic variables and survival outcomes. Int J Gynecol Cancer. 2010 Jul;20(5):888-94.PMID: 20606539
18. Semaan A, Qazi AM, Seward S, Chamala S, Bryant CS, Kumar S, Morris R, Steffes CP, Bouwman DL, Munkarah AR, Weaver DW, Gruber SA, Batchu RB. MicroRNA-101 Inhibits Growth of Epithelial Ovarian Cancer by Relieving Chromatin-Mediated Transcriptional Repression of p21(waf1/cip1). Pharm Res. 2011 Aug 5. PMID: 21818714
19. Sanjeev Kumar, Sudeshna Bandyopadhyay; Assaad Semaan; Jay P Shah; Haider Mahdi; Robert T Morris; Adnan Munkarah; Rouba Ali-fehmi. The Role of Frozen Section in Surgical Staging of low risk Endometrial Cancer. PLoS One. 2011;6(9):e21912. PMID: 21912633
20. Semaan A, Munkarah AR, Arabi H, Bandyopadhyay S, Seward S, Kumar S, Qazi A, Hussein Y, Morris RT, Ali-Fehmi R. Expression of GLUT-1 in epithelial ovarian carcinoma: correlation with tumor cell proliferation, angiogenesis, survival and ability to predict optimal cytoreduction. Gynecol Oncol. 2011 Apr;121(1):181-6. PMID: 21167567
21. Mahdi H, Thrall M, Kumar S, Hanna R, Seward S, Lockhart D, Morris RT, Swensen R, Munkarah AR. The prognostic impact of the ratio of positive lymph nodes on survival of epithelial ovarian cancer patients. J Surg Oncol. 2011 Jun 1;103(7):724-9. PMID: 21241015
22. Mahdi H, Kumar S, Hanna RK, Munkarah AR, Lockhart D, Morris RT, Tamimi H, Swensen RE, Doherty M. Disparities in treatment and survival between African American and White women with vaginal cancer. Gynecol Oncol. 2011 Jul;122(1):38-41. PMID: 21497383
23. Mahdi H, Swensen RE, Munkarah AR, Chiang S, Luhrs K, Lockhart D, Kumar S. Suicide in women with gynecologic cancer. Gynecol Oncol. 2011 Aug;122(2):344-9. PMID: 21561646
24. Mahdi H, Swensen RE, Hanna R, Kumar S, Ali-Fehmi R, Semaan A, Tamimi H, Morris RT, Munkarah AR. Prognostic impact of lymphadenectomy in clinically early stage malignant germ cell tumour of the ovary. Br J Cancer. 2011 Aug 9;105(4):493-7. PMID: 21772335
25. Vay A, Kumar S, Seward S, Semaan A, Schiffer CA, Munkarah AR, Morris RT. Therapy-related myeloid leukemia after treatment for epithelial ovarian carcinoma: An epidemiological analysis. Gynecol Oncol. 2011 Aug 18. PMID: 21855120
26. Sanjeev Kumar, Alexandra Meuter, Prabin Thapa, Carrie Langstraat, Shailendra Giri, Jeremy Chien, Ramandeep Rattan, William Cliby, Viji Shridhar. Metformin intake associates with better survival in ovarian cancer: A case control study. Cancer. 2013 Feb 1;119(3):555-62. PMID: 23208739
27. Mahdi H, Kumar S, Munkarah AR, Abdalamir M, Doherty M, Swensen R. Prognostic impact of marital status on survival of women with epithelial ovarian cancer. Psychooncology. 2011 Sep 15. PMID: 21919121
28. Mahdi H, Kumar S, Al-Wahab Z, Ali-Fehmi R, Munkarah A. Prognostic impact of lymphadenectomy in uterine serous cancer. BJOG. 2012 Jul 25. PMID: 22827595
29. Kumar S, Medeiros F, Dowdy SC, Keeney GL, Bakkum-Gamez JN, Podratz KC, Cliby WA, Mariani A. A prospective assessment of the reliability of frozen section to direct intraoperative decision making in endometrial cancer. Gynecol Oncol. 2012 Aug 29. PMID: 22940491
30. Torres ML, Weaver AL, Kumar S, Uccella S, Famuyide AO, Cliby WA, Dowdy SC, Gostout BS, Mariani A. Risk factors for developing endometrial cancer after benign endometrial sampling. Obstet Gynecol. 2012 Nov;120(5):998-1004. PMID: 23090515 (Lead article)
31. Alhilli MM, Podratz KC, Dowdy SC, Bakkum-Gamez JN, Weaver AL, McGree ME, Kumar S, Keeney GL, Cliby WA, Mariani A. Preoperative Biopsy and Intraoperative Tumor Diameter Predict Lymph Node Dissemination in Endometrial Cancer. Gynecol Oncol. 2012 Oct 17. PMID: 23085458
32. Fotopoulou C, Zang R, Gultekin M, Cibula D, Ayhan A, Liu D, Richter R, Braicu I, Mahner S, Harter P, Trillsch F, Kumar S, Peiretti M, Dowdy SC, Maggioni A, Trope C, Sehouli J. Value of Tertiary Cytoreductive Surgery in Epithelial Ovarian Cancer: An International Multicenter Evaluation. Ann Surg Oncol. 2012 Oct 2. PMID: 23054114
33. Dowdy SC, Borah BJ, Mariani A, Bakkum-Gamez JN, Kumar S, Weaver AL, Mc Gree ME, Haas, LR, Cliby WA, Podratz KC. Prospective assessment of factors predictive of post-operative morbidity and cost in patients with endometrial cancer. Obstet Gynecol. 2012 Dec;120(6):1419-27. PMID: 23168769
34. Torres ML, Hartmann LC, Cliby WA, Kalli KR, Young PM, Weaver AL, Langstraat CL, Jatoi A, Kumar S, Mariani A. Nutritional status, CT body composition measures and survival in ovarian cancer. Gynecol Oncol. 2013 Jun;129(3):548-53. PMID: 23523419
35. Kumar S, Al-Wahab Z, Sarangi S, Woelk J, Morris R, Munkarah A, Dowdy SC, Mariani A, Cliby W. Risk of postoperative venous thromboembolism after minimally invasive surgery for endometrial and cervical cancer is low: a multi-institutional study. Gynecol Oncol. 2013 Jul;130(1):207-12. PMID: 23612315
36. Kumar S, Mariani A, Bakkum-Gamez JN, Weaver AL, McGree ME, Keeney GL, Cliby WA, Podratz KC, Dowdy SC. Risk factors that mitigate the role of paraaortic lymphadenectomy in uterine endometrioid cancer. Gynecol Oncol. 2013 Sep;130(3):441-5. PMID: 23747331
37. Seward S, Semaan A, Qazi AM, Gruzdyn OV, Chamala S, Bryant CC, Kumar S, Cameron D, Sethi S, Ali-Fehmi R, Morris R, Bouwman DL, Munkarah AR, Weaver DW, Gruber SA, Batchu RB. EZH2 blockade by RNA interference inhibits growth of ovarian cancer by facilitating re-expression of p21(waf1/cip1) and by inhibiting mutant p53. Cancer Lett. 2013 Aug 9;336(1):53-60. doi: 10.1016/j.canlet.2013.04.012. Epub 2013 Apr 18. PMID: 23603558
38. Batchu RB, Gruzdyn OV, Bryant CS, Qazi AM, Kumar S, Chamala S, Kung ST, Sanka RS, Puttagunta US, Weaver DW, Gruber SA. Ritonavir-Mediated Induction of Apoptosis in Pancreatic Cancer Occurs via the RB/E2F-1 and AKT Pathways. Pharmaceuticals (Basel). 2014 Jan 9;7(1):46-57. doi: 10.3390/ph7010046. PMID: 24451403
39. Al-Wahab ZR, Kumar S, Mutch DG, Dowdy SC, Hensley SA, Wang Y, Mahdi H, Ali-Fehmi R, Morris RT, Elshaikh M, Munkarah AR. Racial disparities in uterine clear cell carcinoma: a multi-institution study. Int J Gynecol Cancer. 2014 Mar;24(3):541-8. doi: 10.1097/IGC.0000000000000068.
40. Watkins S; Thaker P; Alpa N; Kumar S; Matsuo K; Lutgendorf S; Ramirez P; Sood A; Coleman R. Clinical Impact of Selective and Non-selective Beta Blockers on Survival in Ovarian Cancer Patients". Cancer. 2015 Oct 1;121(19):3444-51. doi: 10.1002/cncr.29392. Epub 2015 Aug 24.
41. Bogani G, Dowdy SC, Cliby WA, Gostout BS, Kumar S, Ghezzi F, Multinu F, Mariani A. Incisional Recurrences After Endometrial Cancer Surgery. Anticancer Res. 2015 Nov;35(11):6097-104.
42. G. Garg, K. Schwartz, S. Kumar, R. T. Morris, R. Ali-Fehmi. Trends in the utilization of adjuvant chemotherapy in early stage endometrial cancer: a SEER-Medicare study. European Journal of Gynecologic Oncology, October 3, 2016
43. Kumar S, Oien DB, Khurana A, Cliby W, Hartmann L, Chien J, Shridhar V. Coiled-Coil and C2 Domain-Containing Protein 1A (CC2D1A) Promotes Chemotherapy Resistance in Ovarian Cancer. Front Oncol. 2019 Oct 1;9:986. doi: 10.3389/fonc.2019.00986. PMID: 31632917; PMCID: PMC6779793.
Presentations
1. KUMAR S, CS Bryant, JP Shah, JJ Ruterbusch, ML Cote, A Vay, LA Solomon, R Ali-Fehmi, RT Morris, JM Malone Jr. (2008, June). Second Neoplasms in survivors of endometrial cancer: Impact of radiation therapy.. Poster presented at: 44th American Society of Clinical Oncology (ASCO) Annual Meeting; Chicago, IL.
2. KUMAR S, J. Pal, C. S. Bryant, S. Chamala, A. Qazi, C. P. Steffes, M. Shammas, D. W. Weaver, J. M. Malone, R. T. Morris, M. Prasad, R. B. Batchu. (2009, February). Ritonavir potentiates the antiproliferative effect of paclitaxel and inhibits cell invasion and migration in ovarian cancer. Poster presented at: SGO 2009, 40TH Annual Meeting; Abstract number 295; San Antonio, TX.
3. KUMAR S, MD, Christopher S Bryant, MD, Aamer Qazi, PhD, Robert T Morris, MD, Chris Steffes, MD, Madhu Prasad, MD, Donald Weaver, MD, Masood A Shammas, PhD and Ramesh B Batchu, PhD. (2008, March). Ritonavir Inhibits Polycomb Group Protein -EZH2 Mediated Suppression of DNA Repair In Ovarian Cancer Cell Lines. Poster presented at: SGI 55th Annual Scientific Meeting 2008; San Diego, CA.
4. KUMAR S, MD, Christopher S. Bryant, M.D., Aamer Qazi, Ph.D., Robert T. Morris, M.D., Chris Steffes, M.D., Madhu Prasad, M.D., Donald Weaver, M.D., Masood Shammas, Ph.D., Ramesh B. Batchu, Ph.D. (2008, April). Ritonavir blocks Akt signaling and exhibits antineoplastic activity in ovarian cancer cell lines.. Poster presented at: AACR (American Association of Cancer Research); Annual Meeting 2008; San Diego, CA.
5. KUMAR S, MD, Jay P. Shah, MD, Christopher S. Bryant, MD, Stacey N. Akers, MD, Agnieszka Vay, MD, Rouba Ali-Fehmi, MD, John M. Malone,MD, Robert T. Morris, MD, Veronica L. Schimp, DO.. (2008, March). The Prevalence and Prognostic Impact of Lymph Node Metastasis in Malignant Germ Cell Tumors of the Ovary. Poster presented at: (SGO) 2008 Annual Meeting (The 39TH Annual Meeting on Women's CancerTM); Tampa, FL.
6. KUMAR S, Mahdi H, Imudia A, Shah JP, Bryant CS, Malone JM. (2009, May). Asynchronuos contralateral ovarian torsion: A single center experience.. Poster presented at: 57th Annual Clinical Meeting of ACOG; Chicago, IL.
7. KUMAR S, Shah JP, Bryant CS, Vay A, Seward S, Mahdi H, Ali-Fehmi R, Morris RT and Malone JM. (2009, February). Radiation-Associated Endometrial Cancer: A Population-Based Case-Control Study.. Poster presented at: SGO 2009, 40TH Annual Meeting; Abstract number 171; San Antonio, TX.
8. SANJEEV KUMAR, MD, Christopher S. Bryant, MD, Aamer Qazi, PhD, Robert T. Morris, MD, Chris Steffes, MD, Madhu Prasad, MD, Donald Weaver, MD, Masood A. Shammas, PhD, Ramesh B. Batchu, PhD,. (2008, March). Ritonavir Exhibits Antineoplastic Activity In Ovarian Cancer Cell Lines By Cell Cycle Arrest And Induction Of Apoptosis. Poster presented at: (SGO) 2008 Annual Meeting (The 39TH Annual Meeting on Women's CancerTM); Tampa, FL.
9. Aamer Qazi, Christopher S Bryant, SANJEEV KUMAR, Madhu Prasad, Christopher P Steffes, David G. Beer, Raj K Goyal, Donald W Weaver, &. Ramesh B Batchu, Masood A Shammas.. (2008, May). Sulforaphane, an antioxidant derived from Broccoli, induces apoptotic cell death in Barrett’s esophageal adenocarcinoma cells. Poster presented at: Digestive Disease Week (DDW); San Diego, CA.
10. Aamer Qazi, Ph.D., Christopher S. Bryant, M.D., SANJEEV KUMAR, MD, Basil F. El-Rayes, M.D., Chris Steffes, M.D., Madhu Prasad, M.D., Donald Weaver, M.D., Masood Shammas, Ph.D., Ramesh B. Batchu, Ph.D. (2008, May). Lentiviral shRNA mediated down modulation of E2F-1 augments ritonavir induced apoptosis in pancreatic adeno-carcinoma. Poster presented at: 11th Annual Meeting of the American Society of Gene Therapy; Boston, MA.
11. Agnieszka Vay, MD, SANJEEV KUMAR, MD, Stacey Akers, MD, Veroinca L. Schimp, DO, Robert T. Morris, MD, Rouba Ali-Fehmi, MD. (2008, March). Comparative Study of Maspin Expression in Type I and Type II Endometrial Carcinoma. Poster presented at: Society of Gynecologic Oncologists (SGO) 2008 Annual Meeting (The 39TH Annual Meeting on Women's CancerTM); Tampa, FL.
12. C. S. Bryant, S. KUMAR, J. P. Shah, A. Vay, S. Seward, R. Ali-Fehmi, G. Deppe, J. M. Malone, R. T. Morris. (2009, February). Comparison of survival disparity between Whites and African-Americans with malignant germ cell tumors of the ovary.. Poster presented at: SGO 2009, 40TH Annual Meeting; Abstract number 238; San Antonio, TX.
13. Christopher S. Bryant, M.D., SANJEEV KUMAR, MD, Basil F. El-Rays, M.D., Aamer Qazi, Ph.D., Chris Steffes, M.D., Madhu Prasad, M.D., Donald Weaver, M.D., Masood Shammas, Ph.D., Ramesh B. Batchu, Ph.D.. (2008, May). Ritonavir, a protease inhibitor, induces apoptosis in pancreatic cancer cells by inhibiting the Akt signaling pathway. Poster presented at: Digestive Disease Week (DDW); San Diego, CA.
14. Christopher S. Bryant, MD, SANJEEV KUMAR, MD, Aamer Qazi, PhD, Rouba Ali-Fehmi, MD, Robert T. Morris, MD, Christopher Steffes, MD, Madhu Prasad, MD, Donald Weaver, MD, Masood Shammas, PhD, Ramesh B. Batchu, PhD. (2008, March). Sulforaphane, An Anti-Oxidant Derived From Broccoli, Induces Cell Cycle Arrest And Apoptosis In Epithelial Ovarian Cancer Cells. Poster presented at: Society of Gynecologic Oncologists (SGO) 2008 Annual Meeting (The 39TH Annual Meeting on Women's CancerTM); Tampa, FL.
15. D Shi, D Thirabanjasak, S Bandyopadhyay, SANJEEV KUMAR, H Arabi, V Schimp, R Morris, A Munkarah, R Ali-Fehmi. (2008, March). Comparative Study of Maspin Expression in Type I and Type II Endometrial Carcinoma. Poster presented at: United States and Canadian Academy of Pathology (USCAP), Annual meeting; Denver, CO.
16. Imudia AN, Chaiworapongsa T, Cordoba M, Dbouk T, SANJEEV KUMAR, Yettaw H, and Mittal P.. (2008, April). Preterm uterine rupture of an unscarred uterus with bilateral fetal ovarian cysts.. Poster presented at: A poster presentation at the Sinai Grace Hospital Research Day, Wayne State University; Detroit, MI.
17. Imudia AN, Cordoba M, Dbouk T, SANJEEV KUMAR, Abdallah ME and Awonuga AO.. (2009, May). Cesarean hysterectomy: does supracervical hysterectomy confer any advantage over total abdominal hysterectomy?. Poster presented at: 57th Annual Clinical Meeting of ACOG. Chicago; Chicago, MI.
18. Jay P. Shah, MD, SANJEEV KUMAR, MD, Christopher S. Bryant, MD, Agnieszka Vay, MD, Leigh A. Solomon, MD, John M. Malone, MD, Rouba Ali-Fehmi, MD, Veronica L. Schimp, MD, Robert T. Morris, MD. (2008, March). An Analysis Of 788 Cases Of Yolk Sac Tumors In Males And Females: A Population Based Study. Poster presented at: Society of Gynecologic Oncologists (SGO) 2008 Annual Meeting (The 39TH Annual Meeting on Women's CancerTM); Tampa, FL.
19. Masood A Shammas, Aamer Qazi, Ramesh B Batchu, Jason YY Wong, Manjula Y Rao, Christopher S Bryant, SANJEEV KUMAR, Madhu Prasad, Christopher P Steffes, Immaculata De Vivo, David G. Beer, Donald W Weaver, & Raj K Goyal.. (2008, May). Telomerase Activity And Telomere Length In LCM Purified Barretts Esophageal Adenocarcinoma Cells. Poster presented at: Digestive Disease Week (DDW); San Diego, CA.
20. Masood A Shammas, Aamer Qazi, Ramesh B Batchu, Robert C Bertheau, Jason YY Wong, Manjula Y Rao, Christopher S Bryant, SANJEEV KUMAR, Madhu Prasad, Selvarangan Ponnazhagan, Diptiman Chanda, Christopher P Steffes, Nikhil C Munshi, Immaculata De Vivo,. (2008, May). Effect of a novel telomerase inhibitor, GRN163L, on growth of Barretts esophageal adenocarcinoma cells in vitro and in vivo. Poster presented at: Digestive Disease Week (DDW); San Diego, CA.
21. R. Ali-Fehmi, A. Munkarah, C. S. Bryant, J. P. Shah, S. KUMAR, J. M. Malone, R. T. Morris, A. K. Sood.. (2009, February). Role of EZH2 in ovarian carcinogenesis. Poster presented at: SGO 2009, 40TH Annual Meeting, Abstract number 296; San Antonio, TX.
22. Christopher S. Bryant, Madhu Prasad, Sanjeev Kumar, Aamer Qazi, Sreedhar Chamala, Jagannath Pal, Jay Shah, Shelly Seward, Masood A. Shammas, Ramesh B. Batchu. Ritonavir Mediated Induction of Apoptosis in Pancreatic Cancer: Involvement of RB/E2F-1 and AKT Pathways. 40th Anniversary meeting of the American Pancreatic Association and Japanese Pancreas Society, Honolulu, Hawaii, Nov 4-7, 2009.
23. R. B. Batchu, A. Semaan, S. M. Seward, A. Qazi, S. Chamala, C. S. Bryant, C. Steffes, S. Kumar, M. A. Shammas, D. W. Weaver. Lentiviral delivery of EzH2 shRNA inhibits tumor growth of epithelial ovarian cancer. American Society of Gene & Cell Therapy (ASGCT) 13th Annual Meeting. Washington DC. May 17-22, 2010.
24. R. B. Batchu, A. Semaan, S. M. Seward, A. Qazi, S. Chamala, C. S. Bryant, C. Steffes, S. Kumar, M. A. Shammas, D. W. Weaver. MiR-101 inhibits cell growth and impedes invasiveness in ovarian cancer cells by targeted epigenetic silencing of EzH2. ASCO Abstract #40308. ASCO Annual Meeting, Chicago, June 4-8, 2010.
25. S. Kumar, K. Podratz, SC. Dowdy, W. Cliby, A. Mariani. Outcomes Assessment Following Treatment of Isolated Lymphatic Recurrences in Endometrial Cancer Patients. SGO 42nd Annual Meeting on Women’s CancerTM; March 6-9, 2011 Orlando, Florida
26. S. Kumar, K. Podratz, SC. Dowdy, J. Bakkum-Gamez, A. Weaver, M. Mc Gree, J. Martin, W. Cliby, A. Mariani. Risk Factors of Thromboembolism Within First 30 Days of Endometrial Cancer Surgery. SGO 42nd Annual Meeting on Women’s CancerTM; March 6-9, 2011 Orlando, Florida
27. H Mahdi, S Kumar, A Munkarah, R Hanna, D Lockhart, H Tamimi, R Swensen, M Doherty. Disparities in treatment and survival between African American and White women with vaginal cancer. SGO 42nd Annual Meeting on Women’s CancerTM; March 6-9, 2011 Orlando, Florida
28. R. B. Batchu, A. M. Qazi, A. Y. Semaan, S. M. Seward, S. Chamala, V. B. Dhulipala, C. David, C. S. Bryant, S. Kumar, C. Steffes, P. Philip, D. Bouwman, D. W. Weaver. Epigenetic Silencing Of EzH2 By RNA Interference As A Potential Therapy For Pancreatic Adenocarcinoma. 6th Annual Academic Surgical Congress. February 1-3, 2011 in Huntington Beach, CA.
Summary Details of Dr. Kumar’s Contributions to The Memphis Community Is Documented Here
Dr. Sanjeev
Kumar
Quick Links
Contact Info
Connect
© 2026 All Rights Reserved | Dr. Sanjeev Kumar
Website Designed & Managed by BJC Media